WHO ICTRP trial
Improving effect of Curcumin on Chemoradiotherapy-Induced Enteritis of…
IRCT20220429054699N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20220429054699N1 |
|---|---|
| Public title | Improving effect of Curcumin on Chemoradiotherapy-Induced Enteritis of colorectal cancer: a randomized, double-blinded, placebo-controlled study |
| Scientific title | Improving effect of Curcumin on Chemoradiotherapy-Induced Enteritis of colorectal cancer: a randomized, double-blinded, placebo-controlled study |
| Primary sponsor | Esfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | RECTAL CANCER. Malignant neoplasm of rectum |
| Interventions | Intervention 1: Intervention group: Curcumin is a medicine to reduce inflammation. In this study, we intended to measure its effect on enterocolitis caused by radiation therapy. Therefore, from the first day for 25-28 days (depending on the… |
| Registration date | Oct 19, 2023 |
| Target size | 56 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: